secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASENSUS SURGICAL, INC. (—)
CIK:        0000876378
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001437749-24-027539
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.01, 3.01, 3.03, 5.01, 5.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KARL STORZ completes acquisition of Asensus Surgical for $0.35 per share in cash
--------------------------------------------------------------------------------

- Merger closed Aug 22, 2024; stockholders received $0.35/share in cash for each share.
- Common stock delisted from NYSE American same day; Form 25 filed with SEC.
- All prior directors resigned; Sonal Matai and Nadim Abi Malhab appointed as directors.
- Warrant holders (2023 and Series D) have 30-day option to require cash purchase at Black-Scholes value.
- Asensus becomes a KARL STORZ subsidiary; CEO Anthony Fernando remains; LUNA robot development continues.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876378/000143774924027539/0001437749-24-027539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876378/000143774924027539/asxc20240820_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-027539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer